The company said there is strong interest in North America for its Healthier Populations solutions and in the fourth quarter it secured a contract with an integrated clinical network.
"We are now seeing market procurement activity returning to historical levels, consistent with our expectations," it said. "Specific opportunities with payers continue to progress and we anticipate additional contractual closures in FY16."
Orion said annualised recurring revenue, its preferred measure of performance, rose 43 per cent to $63 million.
The company, which listed on the New Zealand bourse in November, is foregoing profits and dividends to fund expansion. It is also listed on the ASX. It will release its annual result on May 26.
In a quarterly cash-flow statement released today, Orion said it had cash and short-term deposits of $95 million at its March 31 balance date. Cash receipts from customers in the fourth quarter improved to $53 million, from $30 million in the third quarter, it said.
"Significant quarterly variances in cash receipts are typical for Orion Health due to lumpiness of contract revenues and seasonal factors and quarterly fluctuations are expected to be ongoing," it said.
See Orion's latest business update here: